error
Subscriptions are not available for this site while you are logged into your current account.
close
Skip to main content

Loading

The page is loading.

Please wait...


      The GLP-1 phenomenon has moved far beyond a healthcare story.

      Originally developed for diabetes, GLP-1 medicines are increasingly being used for weight management, lifestyle and wellbeing goals. In parallel, their growing influence is raising important questions for consumer-facing businesses about how behaviours, spending and expectations could change.

      Over two thirds of Consumer CEOs say they are adjusting their product portfolios to reflect changes in demand driven by health-related consumer shifts*. And there are other new questions being prompted that these leaders will need to address:

      • What role might healthcare access, affordability, cultural norms, social media, seasonality and intermittent usage play in shaping future demand across markets, consumer segments and demographics?
      • As healthcare, retail, pharmacy and digital health become increasingly interconnected, how might consumer journeys, access models, ecosystem partnerships and alliance-driven distribution models continue to evolve?
      • As adoption increases and new products enter the market, what role might evolving regulation, transparency and scientific evidence play in shaping consumer trust, business risk, industry responses and competitive dynamics?

      Essentially, for consumer, retail and leisure leaders, the main question should no longer be whether GLP-1s matter, but what they may mean for demand, growth, and value creation. 

      Explore these questions and others in our new report; GLP-1s: Fact, Fiction or Future?

      *KPMG CEO Outlook 2026, survey of 120 Consumer, Retail and Leisure leaders 

      Linda Ellett

      Head of Consumer, Retail

      KPMG in the UK


      Richard Potter

      Partner

      KPMG in the UK



      Are GLP-1s shrinking demand?

       

      Understand how the weight-management drugs are disrupting more than just the food market.

      GLP-1s: Fact, fiction or future podcast

      Our consumer insights

      Something went wrong

      Oops!! Something went wrong, please try again


      MTD

      Get in touch


      Discover why organisations across the UK trust KPMG to make the difference and how we can help you to do the same.